Cannabis hyperemesis syndrome appeared after a chronic user stopped cannabis while traveling to a country with stricter laws

A 33-year-old daily cannabis user developed severe cannabis hyperemesis syndrome about a week after stopping use due to travel, with symptoms overlapping withdrawal and resolving within 10 days on a combination of tramadol, promethazine, and mirtazapine.

Ei Sherif, Yasmine et al.·Consortium psychiatricum·2024·Preliminary EvidenceCase Report
RTHC-05290Case ReportPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

CHS symptoms (severe vomiting, abdominal pain, fever) emerged approximately one week after cessation of daily cannabis use, with standard anti-emetics (ondansetron) failing. The patient also had anxiety, depression, and brain fog consistent with cannabis withdrawal. A combination of tramadol, promethazine, and mirtazapine as outpatient treatment led to full recovery within 10 days.

Key Numbers

33-year-old male. Daily cannabis user for several years. Symptoms began approximately 1 week after stopping. Ondansetron was ineffective. Full recovery within 10 days on tramadol, promethazine, and mirtazapine.

How They Did This

Single case report of a 33-year-old male chronic daily cannabis user who stopped using due to travel to a country with stricter cannabis laws.

Why This Research Matters

This case highlights that CHS can emerge after cannabis cessation, not just during active use, and can overlap with withdrawal symptoms. The successful treatment combination offers an alternative when standard anti-emetics fail.

The Bigger Picture

The overlap between CHS and cannabis withdrawal suggests these may be related manifestations of the same underlying dysregulation, and clinicians should consider both diagnoses when chronic cannabis users present with GI symptoms after cessation.

What This Study Doesn't Tell Us

Single case report. Cannot generalize treatment response to other patients. Patient also used tobacco and alcohol, which were continued. Exact cannabis doses and duration not quantified.

Questions This Raises

  • ?How often does CHS present during cessation rather than active use?
  • ?Is the tramadol-promethazine-mirtazapine combination effective in other CHS cases?

Trust & Context

Key Stat:
CHS emerged after cessation, not during active use
Evidence Grade:
Single case report. Illustrative but cannot establish treatment efficacy or generalizability.
Study Age:
2024 study
Original Title:
Cannabis Hyperemesis Syndrome in a Recently Abstinent Chronic User: Assessment and Intervention.
Published In:
Consortium psychiatricum, 5(1), 27-32 (2024)
Database ID:
RTHC-05290

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

Can CHS happen after stopping cannabis?

This case and others suggest yes. While CHS is typically associated with active chronic use, symptoms can emerge or worsen shortly after cessation, possibly overlapping with the withdrawal syndrome.

Why did standard anti-nausea medication not work?

CHS is notoriously resistant to conventional anti-emetics like ondansetron. The mechanism of CHS-related vomiting differs from typical nausea and may involve cannabinoid receptor dysregulation in the gut and brain that these medications do not address.

Read More on RethinkTHC

Cite This Study

RTHC-05290·https://rethinkthc.com/research/RTHC-05290

APA

Ei Sherif, Yasmine; Gouher, Sariah; Abualhab, Mutaz Mohsin; El-Khoury, Joseph. (2024). Cannabis Hyperemesis Syndrome in a Recently Abstinent Chronic User: Assessment and Intervention.. Consortium psychiatricum, 5(1), 27-32. https://doi.org/10.17816/CP15473

MLA

Ei Sherif, Yasmine, et al. "Cannabis Hyperemesis Syndrome in a Recently Abstinent Chronic User: Assessment and Intervention.." Consortium psychiatricum, 2024. https://doi.org/10.17816/CP15473

RethinkTHC

RethinkTHC Research Database. "Cannabis Hyperemesis Syndrome in a Recently Abstinent Chroni..." RTHC-05290. Retrieved from https://rethinkthc.com/research/ei-2024-cannabis-hyperemesis-syndrome-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.